CME: Mixed Street Views And New Markets Will Shape Future Earnings Power

Narrative Update on CME Group

The analyst price target for CME Group has been trimmed by about $2, reflecting updated views on slightly softer revenue growth and a modestly lower future P/E multiple. At the same time, some analysts highlight areas of support such as commodities volumes as well as agriculture and prediction markets.

Analyst Commentary

Recent research on CME Group has been active on both sides, with some bullish analysts lifting targets and ratings, while more cautious analysts trim price targets or shift to neutral stances. For you as an investor, the spread in views largely comes down to how confident each camp is about volumes across different product lines, expense trends, and what multiple the stock should trade on.

Bullish Takeaways

Bullish analysts who raised price targets or upgraded ratings point to support from commodities volumes, especially where quarter to date activity in certain contracts feeds into slightly higher earnings estimates.
Some see agriculture and prediction markets as capable of offsetting softer trends in equity index, metals, crypto and micro contracts, which keeps their growth outlook more balanced across the product mix.
Target increases in recent research imply that these analysts are comfortable with current execution on the core franchise and are prepared to underwrite a valuation that reflects steady earnings power rather than material downside risk.
Where the stock is rated at or above neutral, commentary often highlights that the existing business model and diversified product set can support earnings even when individual contract categories see slower growth.

Bearish Takeaways

Bearish analysts cutting targets by a few dollars cite expectations for softer revenue growth and a modestly lower future P/E multiple, which pulls their valuation work closer to the current share price.
One downgrade to Hold cites "muted growth" in equity index, metals, crypto and micro contracts from retail investors, suggesting that some parts of the business may not be strong enough, on their view, to justify a richer multiple.
Even where price targets are raised, some research keeps ratings at Underperform or Hold, reflecting concern that a higher expense outlook could offset the benefit of stronger commodities volumes over time.
Overall, the more cautious camp is focused on execution risk around managing costs and on whether growth in agriculture and prediction markets can fully counterbalance softer areas, which keeps them hesitant to assign a premium valuation.

What's in the News

CME Group and Silicon Data plan to launch a compute futures market tied to daily GPU rental benchmarks, aimed at giving traders, AI builders and cloud providers tools to manage volatility and price risk in the multi trillion dollar compute market, pending regulatory review.
CME Group listed new Avalanche and Sui futures, with first trades executed as block transactions between FalconX and G 20 Group, and plans to offer cryptocurrency futures and options trading 24 hours a day, seven days a week starting May 29.
CME Group introduced the U.S. dollar RepoFunds Rate benchmark, using centrally cleared overnight U.S. repo data from the BrokerTec platform to provide same day transparency on funding costs and a reference rate for derivatives and floating rate instruments.
AWS experienced a data center outage in northern Virginia that disrupted several platforms, with reports of issues at CME Group and Coinbase, although the link between CME's issues and the AWS problem was not clearly established. (Reuters)
Interactive Brokers is expanding access to prediction markets through Kalshi, CME Group and its own ForecastEx platform, focusing on contracts tied to elections, climate and the economy rather than sports or pop culture. (Wall Street Journal)

Valuation Changes

Fair Value: Trimmed slightly from $308.20 to $306.60, reflecting a modest adjustment to the internal estimate of what the stock may be worth.
Discount Rate: Eased marginally from 7.87% to 7.85%, indicating a slightly lower hurdle rate applied to future cash flows.
Revenue Growth: Assumptions softened a bit from 5.15% to 5.13%, pointing to a slightly more conservative view on future dollar revenue expansion.
Net Profit Margin: Edged up from 58.33% to 58.37%, suggesting a small improvement in expected profitability on each dollar of revenue.
Future P/E: Reduced modestly from 31.13x to 30.95x, implying a slightly lower valuation multiple applied to projected earnings.

5 views

Key Takeaways

Strong global demand for risk management, retail engagement, and international expansion drives volume and revenue growth, diversifying CME's client base.
Innovation in products, technology, and partnerships enhances efficiency and margins, positioning CME for sustainable long-term earnings growth.
Competitive threats from DeFi, regulatory shifts, and low volatility could erode CME Group's market share, trading volumes, and profit margins over time.

Catalysts

About CME Group

Operates contract markets for the trading of futures and options on futures contracts worldwide.What are the underlying business or industry changes driving this perspective?

Heightened global macroeconomic uncertainty, record sovereign debt issuance, persistent geopolitical tensions, and ongoing trade disputes are fueling sustained demand for risk management and hedging solutions, evidenced by record contract volumes and open interest; this trend is likely to support continued revenue and fee growth.
Robust international expansion-with record-breaking double-digit ADV growth across EMEA and APAC and rising participation from both institutional and retail clients globally-broadens CME's addressable market and underpins future volume and revenue growth.
The rapid acceleration of retail engagement, highlighted by a 56% increase in new retail traders and five consecutive quarters of double-digit retail client acquisition growth, diversifies CME's client base and supports both volume and transaction-based revenue growth.
New product innovations (e.g., Micro contracts, expansion into crypto, FX Spot+), ongoing tech-driven operating efficiencies (cloud migration and tokenization initiatives), and strengthening of strategic partnerships (such as the long-term NASDAQ index license extension and Google Cloud collaboration) are enhancing operating leverage and EBITDA/net margin performance.
The ongoing global shift toward electronic trading, greater regulatory demands for transparency and standardized clearing, and a proven ability to grow non-transactional revenue (e.g., record market data revenue) position CME to capture a larger share of trading activity and support durable long-term earnings growth.

CME Group Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming CME Group's revenue will grow by 5.1% annually over the next 3 years.
Analysts assume that profit margins will shrink from 62.9% today to 58.4% in 3 years time.
Analysts expect earnings to reach $4.6 billion (and earnings per share of $13.27) by about May 2029, up from $4.2 billion today.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 31.0x on those 2029 earnings, up from 25.4x today. This future PE is lower than the current PE for the US Capital Markets industry at 41.2x.
Analysts expect the number of shares outstanding to grow by 0.56% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 7.85%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Prolonged periods of geopolitical stability and reduced headline risk could curb market volatility, lowering overall demand for risk-hedging and derivatives trading, which may lead to declining trading volumes and negatively impact CME Group's revenue and earnings growth.
The accelerating adoption of decentralized finance (DeFi) and tokenization technologies poses a long-term competitive threat, as new market structures could enable trading and settlement of derivatives outside of centralized venues like CME, potentially reducing future market share and fee revenues.
CME's continued heavy reliance on trading activity in interest rate and equity futures exposes the company to periods of subdued volatility or volume in those sectors, which could result in revenue stagnation or contraction and put pressure on net margins.
Regulatory changes-such as potential increased oversight of retail derivatives trading, limitations on certain products (e.g., perpetuals in the U.S.), or global moves to further tighten derivatives market participation-may dampen speculative activity and reduce overall transaction fees and open interest.
Intensifying industry competition from alternative electronic trading venues, lower-fee platforms, and the proliferation of OTC derivatives and algorithmic solutions could create sustained pricing pressure, eroding net margins and constraining CME's long-term earnings growth.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $306.6 for CME Group based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $353.0, and the most bearish reporting a price target of just $230.0.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $7.8 billion, earnings will come to $4.6 billion, and it would be trading on a PE ratio of 31.0x, assuming you use a discount rate of 7.8%.
Given the current share price of $297.7, the analyst price target of $306.6 is 2.9% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on CME Group?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

EMEA And APAC Expansion Combined With Rising Retail Demand Will Shape Future Trading